| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/16/2003 | CN1105720C Imidazopyridazines compound |
| 04/16/2003 | CN1105718C Improved method for producing thiazolidinediones, and new thiazolidinediones |
| 04/16/2003 | CN1105716C Benzimidazole derivatives with antihistaminic activity |
| 04/16/2003 | CN1105715C New pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising same as active ingredient |
| 04/16/2003 | CN1105711C 嘧啶衍生物 Pyrimidine derivatives |
| 04/16/2003 | CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 04/16/2003 | CN1105705C Process for preparing heterocyclic amide derivative with specific physical status |
| 04/16/2003 | CN1105577C Parathyroid hormone and raloxifene for increasing bone mass |
| 04/16/2003 | CN1105576C Insulin analog formulation |
| 04/16/2003 | CN1105575C Lyophilized stem celi factor formulations |
| 04/16/2003 | CN1105573C Pharmaceutical composition |
| 04/16/2003 | CN1105564C Medicine for warming kidney and treating wind-dampness syndrome and preparation process thereof |
| 04/16/2003 | CN1105561C Medicine for treating underarm odour and beriberi |
| 04/16/2003 | CN1105560C Use of efaroxan for producing medicine for treating huntington disease |
| 04/16/2003 | CN1105559C Anticonvulsant derivative useful in treating neuropathic pain |
| 04/16/2003 | CN1105558C 2,2-dichloroalkane carboxylic acids, process for preparing same, medicament containing same and use for treating insulin resistance |
| 04/16/2003 | CN1105554C Skin care compositions containing combinations of compounds for mimicking effect on skin of retinoic acid |
| 04/16/2003 | CN1105506C 碳水化合物混合物 Carbohydrate blend |
| 04/16/2003 | CA2407771A1 Mixtures for stimulating glucose up-take |
| 04/15/2003 | WO2002089822A1 Bactericidal disinfectant, antibacterial drug, and antibacterial material |
| 04/15/2003 | USRE38081 Method of hemodilution facilitated by monitoring oxygenation status |
| 04/15/2003 | US6548715 Which lacks the combined presence of the trans-fused ring; increased therapeutic potential; for cell proliferation; veterinary medicine |
| 04/15/2003 | US6548699 4,4*-(Isopropylidenedithio)-(2*,6*-di-tert-butylphenol)-(2,6-d i-tert-butylphenol-O*-acetic acid); antiarthritic, antiinflammatory agents; rheumatic and cardiovascular disorders |
| 04/15/2003 | US6548694 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 04/15/2003 | US6548693 Nitriloxy derivatives of (R) and (S)-carnitine |
| 04/15/2003 | US6548687 Chromium L-threonate, process for preparation of the same and their use |
| 04/15/2003 | US6548679 Antitumor agents |
| 04/15/2003 | US6548675 1-Cyclopropylcarbonyl-2-hydroxy(optional),4-isopropylbenzene used as starting materials for 1-((2-hydroxy(optional),4-alkylphenyl)carbonylalkyl-),4-(diphenylmethyl -)piperidine derivatives; antihistamines; antiallergens; bronchodilators |
| 04/15/2003 | US6548671 Quinoxalinyl amide derivatives |
| 04/15/2003 | US6548668 Stabilizer for proteins |
| 04/15/2003 | US6548667 For prevention and treatment of diseases caused by overexpression and overactivation of matrix metalloproteinase |
| 04/15/2003 | US6548666 Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them |
| 04/15/2003 | US6548665 Asymmetric synthesis of a key intermediate for making benazepril and analogues thereof |
| 04/15/2003 | US6548554 Ionic aqueous composition containing levomenthol |
| 04/15/2003 | US6548551 Administration of Citalopram and Phentermine to facilitate weight loss for patient |
| 04/15/2003 | US6548550 Treating eosinophilic granuloma in cats |
| 04/15/2003 | US6548548 Cardiovascular disorders; anticholesterol agents |
| 04/15/2003 | US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators |
| 04/15/2003 | US6548546 HIV integrase inhibitors |
| 04/15/2003 | US6548545 Treatment of interstitial cystitis using topical application of menthol and L-arginine |
| 04/15/2003 | US6548544 Method of treatment of priapism without raising systemic blood pressure |
| 04/15/2003 | US6548543 Administering as antiinflammatory agents, fungicides, tumor necrosis factor inhibitors, immunomodulators, heat shock protein inductors, and cellular adhesion controllers |
| 04/15/2003 | US6548542 Vision through photodynamic therapy of the eye |
| 04/15/2003 | US6548541 Carboplatin analogs for cancer treatment |
| 04/15/2003 | US6548540 Administering dithiocarbamate thiolate anions to sensitize humans to conventional chemotherapy by blocking the p-glycoprotein membrane toxin extrusion pump |
| 04/15/2003 | US6548536 Tetrocarcin derivative; treating cancer, AIDS, AIDS related condition (ARC), osteoarthritis, autoimmune diseases, collagenosis, and arteriosclerosis |
| 04/15/2003 | US6548535 Administering indole diterpene compounds as potent potassium channel blockers |
| 04/15/2003 | US6548533 Pyrrolidine carboxylic Acid or ester derivatives are useful for treating alpha 4 beta 1 mediated cell adhesion |
| 04/15/2003 | US6548532 Topically applying onto the afflicted skin and/or scalp cosmetically/ therapeutically effective amount of indolecarboxylic acid compound, or ester or salt thereof |
| 04/15/2003 | US6548531 Bis-indol-3-yl 3-pyrroline derivatives and paclitaxel |
| 04/15/2003 | US6548530 Antitumor drugs incorporate the 1,2,9,9a-tetrahydrocyclopropa(c)benz(e)indol-4-one (CBI) alkylation subunit; cytotoxic activity |
| 04/15/2003 | US6548529 Heterocyclic containing biphenyl aP2 inhibitors and method |
| 04/15/2003 | US6548527 Treatments for immune-mediated ear disorders |
| 04/15/2003 | US6548526 Isothiazole derivatives useful as anticancer agents |
| 04/15/2003 | US6548522 N-substituted 2,2-diphenylacetamide or N-substituted 2-phenyl-2-pyridinylacetamide |
| 04/15/2003 | US6548521 Use of aromatic a,b-unsaturated ketone derivatives treating malaria, schistosomiasis and other infectious diseases |
| 04/15/2003 | US6548520 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/15/2003 | US6548518 As well as 5-HT3 antagonists and 5-HT4 agonists; for preventing or managing gastro-esophageal reflux disease and/or emesis |
| 04/15/2003 | US6548516 (NMDA=N-methyl-D-aspartate); where the heteroaryl is 3H-benzoxazol-2-one, 3H-benzothiazol-2-one, 3H-benzimidazol-2-one or indolin-2-one; excitatory amino acid antagonists for combating neurodegenerative disorders |
| 04/15/2003 | US6548515 Use as anticancer agents |
| 04/15/2003 | US6548514 Inhibitors of p38 kinase/cytokine suppressive binding protein (CSBP)/reactivating kinase (RK); 1-((pyridyl)aminocarbonyl)-3-((hetero)arylaminocarbonyl)benzene derivatives; treating cytokine related diseases and disorders |
| 04/15/2003 | US6548513 (E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(methyl -sulfonyl)amino)pyrimidin-5-yl)-(3R,5S)-3,5-dihydroxyhept-6-enoic acid or salt, stabilized by an inorganic salt having a multivalent cation, excluding synthetic hydrotalcite |
| 04/15/2003 | US6548510 Pharmaceutical composition containing deoxypeganine for the treatment of nicotine dependence |
| 04/15/2003 | US6548509 3-aryl substituted pyrazolo[4,3-D]pyrimidine derivatives; corticotropin-releasing factor receptor (CRF1) specific ligands |
| 04/15/2003 | US6548508 Animal growth regulator |
| 04/15/2003 | US6548507 Use of sodium channel antagonists in the treatment of diseases mediated or exacerbated by neuronal apoptosis, such as multiple sclerosis; administering drugs such as lamotrigine |
| 04/15/2003 | US6548506 1-substituted,3-carboxy,7-fluoro,8-disubstituted amino-1,4-dihydrobenzo(b)(1,8)naphthyridin-4-ones; Useful as antimicrobial agents; topical antibiotic for wounds |
| 04/15/2003 | US6548505 Radioprotectors |
| 04/15/2003 | US6548504 Compounds |
| 04/15/2003 | US6548503 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 04/15/2003 | US6548502 Preventing disorder selected from pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction such as drug and alcohol and sex in a mammals by administering pyrido(1,2-a) pyrazine derivatives |
| 04/15/2003 | US6548501 Composition and methods for stimulating gastrointestinal motility |
| 04/15/2003 | US6548500 Treating a cell adhesion-mediated diseases such as multiple sclerosis, asthma, atherosclerosis, rheumatoid arthritis, meningitis, comprising administering to a warm blooded animal a nitrogen atoms containing bicyclic compound |
| 04/15/2003 | US6548498 Substituted indan derivatives |
| 04/15/2003 | US6548497 Methods of reducing non-inflammatory pain |
| 04/15/2003 | US6548496 Substituted 3-cyano-[1.7], [1.5], and [1.8] naphthyridine inhibitors of tyrosine kinases |
| 04/15/2003 | US6548495 Dihydro-benzo [B] [1,4] diazepin-2-one derivatives |
| 04/15/2003 | US6548494 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases |
| 04/15/2003 | US6548493 Substituted heterocycle fused gamma-carbolines |
| 04/15/2003 | US6548492 Process for formulation of carbapenem antibiotic compositions |
| 04/15/2003 | US6548490 Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
| 04/15/2003 | US6548488 Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer |
| 04/15/2003 | US6548487 Agent for treatment of bladder troubles |
| 04/15/2003 | US6548486 New viricide compounds of the general formula: Nu-O-Fa, wherein O represents an oxygen, Nu is a nucleoside or nucleoside analogue, and Fa is an acyl group of mono-unsaturated c18-c20 fatty acid |
| 04/15/2003 | US6548484 An amidation product of ribosyl or glucosyl saccharide and a dopamine or derivative ( forms a amide through amine and carboxylic group); useful for treating neurological diseases including Parkinson's and related diseases |
| 04/15/2003 | US6548483 Nutritional preparation comprising ribose and medical use thereof |
| 04/15/2003 | US6548481 A salt form of a dipeptide compound formed from an amino acid and a thiazolidine or pyrrolidine group, and the salts are selected from acetates, tartrates, fumarates, succinates, phosphates and sulfates |
| 04/15/2003 | US6548480 Reacting a phosphorylated derivatives with a dipeptide to displace halogen atom of phosphorylated derivative, deprotecting to form a phosphonic acid derivative; neutral endopeptidase and angiotensin converting enzyme inhibitor |
| 04/15/2003 | US6548478 Virginiamycin mixture |
| 04/15/2003 | US6548476 Dimeric inhibitors of influenza neuraminidase |
| 04/15/2003 | US6548265 Treatment or prophylaxis of diseases caused by pilus-forming bacteria |
| 04/15/2003 | US6548095 Sugar-free compressed products |
| 04/15/2003 | US6548086 Controlling immunology response; administering plant extract;side effect reduction |
| 04/15/2003 | US6548084 Controlled release compositions |
| 04/15/2003 | US6548083 Prolonged release active agent dosage form adapted for gastric retention |
| 04/15/2003 | US6548082 Sleep disorders |
| 04/15/2003 | US6548079 Moxifloxacin formulation containing common salt |
| 04/15/2003 | US6548078 Implanting a sustained release device to deliver the corticosteroid to the vitreous of the eye and wherein aqueous corticosteroid concentration is less than vitreous corticosteroid concentration during release |
| 04/15/2003 | US6548075 Mixture containing polyglucans |